- Home
- ALLO vs CCSI Comparison
ALLO vs CCSI Comparison
Compare ALLO & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | CCSI |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.7M | 683.1M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALLO | CCSI |
|---|---|---|
| Price | $1.69 | $35.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | $8.35 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 4.8M | 161.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ 2.72 |
| Revenue | N/A | ★ $349,696,000.00 |
| Revenue This Year | N/A | $3.33 |
| Revenue Next Year | $142,416.42 | $2.70 |
| P/E Ratio | ★ N/A | $13.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $20.20 |
| 52 Week High | $4.46 | $41.40 |
Technical Indicators
Market Signals| Indicator | ALLO | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 42.88 |
| Support Level | $1.59 | $32.86 |
| Resistance Level | $1.92 | $36.36 |
| Average True Range (ATR) | 0.08 | 1.69 |
| MACD | -0.03 | -0.12 |
| Stochastic Oscillator | 6.58 | 34.91 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.